DNA methylation plays an important role in the epigenetic regulation of mammalian gene expression. TET (ten-eleven translocation) proteins, newly discovered demethylases, have sparked great interest since their discovery. TET proteins catalyze 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine in 3 consecutive Fe(II)- and 2-oxoglutarate (2-OG)-dependent oxidation reactions. TET proteins dynamically regulate global or locus-specific 5-methylcytosine and/or 5-hydroxymethylcytosine levels by facilitating active DNA demethylation. In fact, in addition to their role as methylcytosine dioxygenases, TET proteins are closely related to histone modification, interact with metabolic enzymes as well as other proteins, and cooperate in transcriptional regulation. In this review, we summarize the recent progress in this exciting field, highlighting the molecular mechanism by which TET enzymes regulate gene expression and their functions in health and disease. We also discuss the therapeutic potential of targeting TET proteins and aberrant DNA modifications.

Keywords:
5-Hydroxymethylcytosine, Development, Differentiation, DNA demethylation, DNA methylation, Epigenetic therapy, GlcNAcylation, Histone modification, TET protein, Transformation
1.
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, et al: Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114:144-147 (2009).
2.
Arioka Y, Watanabe A, Saito K, Yamada Y: Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins. PloS One 7:e45031 (2012).
3.
Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, et al: Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica 98:1912-1920 (2013).
4.
Blaschke K, Ebata KT, Karimi MM, Zepeda-Martinez JA, Goyal P, et al: Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500:222-226 (2013).
5.
Bradley-Whitman MA, Lovell MA: Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev 134:486-495 (2013).
6.
Chen H, Dzitoyeva S, Manev H: Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor Neurol Neurosci 30:237-245 (2012).
7.
Chen Q, Chen Y, Bian C, Fujiki R, Yu X: TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493:561-564 (2013).
8.
Coskun V, Tsoa R, Sun YE: Epigenetic regulation of stem cells differentiating along the neural lineage. Curr Opin Neurobiol 22:762-767 (2012).
9.
Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, et al: NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 495:370-374 (2013).
10.
Dawlaty MM, Breiling A, Le T, Barrasa MI, Raddatz G, et al: Loss of Tet enzymes compromises proper differentiation of embryonic stem cells. Dev Cell 29:102-111 (2014).
11.
Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, et al: Mutation in TET2 in myeloid cancers. N Engl J Med 360:2289-2301 (2009).
12.
Deplus R, Delatte B, Schwinn MK, Defrance M, Mendez J, et al: TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 32:645-655 (2013).
13.
Dickson KM, Gustafson CB, Young JI, Zuchner S, Wang G: Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. Biochem Biophys Res Commun 439:522-527 (2013).
14.
Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S, et al: Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488:652-655 (2012).
15.
Dong C, Zhang H, Xu C, Arrowsmith CH, Min J: Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation. IUCrJ 1:540-549 (2014).
16.
Dong E, Gavin DP, Chen Y, Davis J: Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry 2:e159 (2012).
17.
Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, et al: Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:553-567 (2010).
18.
Fong JJ, Nguyen BL, Bridger R, Medrano EE, Wells L, et al: Beta-N-acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J Biol Chem 287:12195-12203 (2012).
19.
Fu X, Jin L, Wang X, Luo A, Hu J, et al: MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation. Proc Natl Acad Sci USA 110:17892-17897 (2013).
20.
Fujiki R, Hashiba W, Sekine H, Yokoyama A, Chikanishi T, et al: GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 480:557-560 (2011).
21.
Gavin DP, Chase KA, Sharma RP: Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology 75:233-245 (2013).
22.
Gu TP, Guo F, Yang H, Wu HP, Xu GF, et al: The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477:606-610 (2011).
23.
Hahn MA, Qiu R, Wu X, Li AX, Zhang H, et al: Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep 3:291-300 (2013).
24.
Hashimoto H, Pais JE, Zhang X, Saleh L, Fu ZQ, et al: Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA. Nature 506:391-395 (2014).
25.
He YF, Li BZ, Li Z, Liu P, Wang Y, et al: Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:1303-1307 (2011).
26.
Hu L, Li Z, Cheng J, Rao Q, Gong W, et al: Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155:1545-1555 (2013).
27.
Ichiyama K, Chen T, Wang X, Yan X, Kim BS, et al: The methylcytosine dioxygenase TET2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42:613-626 (2015).
28.
Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, et al: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129-1133 (2010).
29.
Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al: Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300-1303 (2011).
30.
Ivanov M, Kals M, Kacevska M, Barragan I, Kasuga K, et al: Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function. Genome Biol 14:R83 (2013).
31.
Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, et al: Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 113:6403-6410 (2009).
32.
Jin SG, Wu X, Li AX, Pfeifer GP: Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39:5015-5024 (2011).
33.
Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A, et al: The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res 15:483-494 (2012).
34.
Kizuka Y, Kitazume S, Okahara K, Villagra A, Sotomayor EM, et al: Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. J Biol Chem 289:11253-11261 (2014).
35.
Ko M, An J, Bandukwala HS, Chavez L, Aijo T, et al: Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 497:122-126 (2013).
36.
Kohli RM, Zhang Y: TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472-479 (2013).
37.
Kosmider O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V, et al: TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood 114:3285-3291 (2009).
38.
Kubiura M, Okano M, Kimura H, Kawamura F, Tada M: Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res 20:837-848 (2012).
39.
Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, et al: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 103:670-676 (2012).
40.
Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, et al: Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 41:838-842 (2009).
41.
Lemonnier F, Couronne L, Parrens M, Jais JP, Travert M, et al: Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120:1466-1469 (2012).
42.
Li T, Yang D, Li J, Tang Y, Yang J, et al: Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation. Mol Neurobiol 51:142-154 (2015).
43.
Li Y, O'Neill C: 5′-Methylcytosine and 5′-hydroxymethylcytosine each provide epigenetic information to the mouse zygote. PloS One 8:e63689 (2013).
44.
Li Z, Cai X, Cai CL, Wang J, Zhang W, et al: Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118:4509-4518 (2011).
45.
Lian CG, Xu Y, Ceol C, Wu F, Larson A, et al: Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135-1146 (2012).
46.
Liu N, Wang M, Deng W, Schmidt CS, Qin W, et al: Intrinsic and extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules. PloS One 8:e62755 (2013).
47.
Liu R, Jin Y, Tang WH, Qin L, Zhang X, et al: Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation 128:2047-2057 (2013).
48.
Liu Y, Jiang W, Liu J, Zhao S, Xiong J, et al: IDH1 mutations inhibit multiple alpha-ketoglutarate-dependent dioxygenase activities in astroglioma. J Neurooncol 109:253-260 (2012).
49.
Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560 (2007).
50.
Minor EA, Court BL, Young JI, Wang G: Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem 288:13669-13674 (2013).
51.
Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, et al: Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20:11-24 (2011).
52.
Nakamura T, Liu YJ, Nakashima H, Umehara H, Inoue K, et al: PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos. Nature 486:415-419 (2012).
53.
Neri F, Incarnato D, Krepelova A, Rapelli S, Pagnani A, et al: Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol 14:R91 (2013).
54.
Neri F, Incarnato D, Krepelova A, Rapelli S, Anselmi F, et al: Single-base resolution analysis of 5-formyl and 5-carboxyl cytosine reveals promoter DNA methylation dynamics. Cell Rep doi:10.1016/j.celrep.2015.01.008 (2015).
55.
Okashita N, Kumaki Y, Ebi K, Nishi M, Okamoto Y, et al: PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells. Development 141:269-280 (2014).
56.
Orr BA, Haffner MC, Nelson WG, Yegnasubramanian SE, Eberhart CG: Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PloS One 7:e41036 (2012).
57.
Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, et al: Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473:394-397 (2011).
58.
Prosdocimo DA, Jain R, Jain MK: UnTEThering (smooth muscle) cell plasticity. Circulation 128:2002-2004 (2013).
59.
Qian H, Xu X: Reduction in DNA methyltransferases and alteration of DNA methylation pattern associate with mouse skin ageing. Exp Dermatol 23:357-359 (2014).
60.
Quivoron C, Couronne L, Della Valle V, Lopez CK, Plo I, et al: TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20:25-38 (2011).
61.
Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR, et al: Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol 13:R69 (2012).
62.
Rose NR, McDonough MA, King ON, Kawamura A, Schofield CJ: Inhibition of 2-oxoglutarate dependent oxygenases. Chem Soc rev 40:4364-4397 (2011).
63.
Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, et al: Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79:1109-1122 (2013).
64.
Shen L, Wu H, Diep D, Yamaguchi S, D'Alessio AC, et al: Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153:692-706 (2013).
65.
Shim EH, Livi CB, Rakheja D, Tan J, Benson D, et al: L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4:1290-1298 (2014).
66.
Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, et al: Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153:678-691 (2013).
67.
Song SJ, Ito K, Ala U, Kats L, Webster K, et al: The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13:87-101 (2013).
68.
Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE: 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biology 12:R54 (2011).
69.
Sui X, Price C, Li Z, Chen J: Crosstalk between DNA and histones: Tet's new role in embryonic stem cells. Curr Genomics 13:603-608 (2012).
70.
Sun Z, Dai N, Borgaro JG, Quimby A, Sun D, et al: A sensitive approach to map genome-wide 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution. Mol Cell 57:750-761 (2015).
71.
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-935 (2009).
72.
Valinluck V, Sowers LC: Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67:946-950 (2007).
73.
Vella P, Scelfo A, Jammula S, Chiacchiera F, Williams K, et al: Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 49:645-656 (2013).
74.
Wang T, Wu H, Li Y, Szulwach KE, Lin L, et al: Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol 15:700-711 (2013).
75.
Williams K, Christensen J, Helin K: DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep 13:28-35 (2012).
76.
Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V, et al: 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2:241 (2011).
77.
Wu H, Zhang Y: Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells. Cell Cycle 10:2428-2436 (2011).
78.
Wu H, D'Alessio AC, Ito S, Wang Z, Cui K, et al: Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25:679-684 (2011).
79.
Wu Y, Guo Z, Liu Y, Tang B, Wang Y, et al: Oct4 and the small molecule inhibitor, SC1, regulates Tet2 expression in mouse embryonic stem cells. Mol Biol Rep 40:2897-2906 (2013).
80.
Xu Y, Wu F, Tan L, Kong L, Xiong L, et al: Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42:451-464 (2011).
81.
Yamaguchi S, Hong K, Liu R, Inoue A, Shen L, et al: Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res 23:329-339 (2013a).
82.
Yamaguchi S, Shen L, Liu Y, Sendler D, Zhang Y: Role of Tet1 in erasure of genomic imprinting. Nature 504:460-464 (2013b).
83.
Yang H, Liu Y, Bai F, Zhang JY, Ma SH, et al: Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32:663-669 (2013).
84.
Yang Q, Wu K, Ji M, Jin W, He N, et al: Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J Biomed Nanotechnol 9:1607-1616 (2013).
85.
Yin R, Mao SQ, Zhao B, Chong Z, Yang Y, et al: Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc 135:10396-10403 (2013).
86.
Zhang P, Huang B, Xu X, Sessa WC: Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. Biochem Biophys Res Commun 437:368-373 (2013).
87.
Zhang S, Roche K, Nasheuer HP, Lowndes NF: Modification of histones by sugar beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 286:37483-37495 (2011).
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.